These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31156432)

  • 1. Are Patients With
    Palermo S; Giovannelli F; Bartoli M; Amanzio M
    Front Pharmacol; 2019; 10():502. PubMed ID: 31156432
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction.
    Glissen Brown JR; Sanayei A; Proctor S; Flanagan R; Ballou S; Bain PA; Nee J
    Am J Gastroenterol; 2023 Apr; 118(4):692-701. PubMed ID: 36563308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis.
    Sung YK; Lee YH
    Z Rheumatol; 2022 Jun; 81(5):430-437. PubMed ID: 33687525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials.
    Zis P; Mitsikostas DD
    J Neurol Sci; 2015 Aug; 355(1-2):94-100. PubMed ID: 26073486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies.
    Zaccara G; Giovannelli F; Franco V; Cincotta M; Tramacere L; Verrotti A
    Epilepsy Res; 2014 Dec; 108(10):1685-93. PubMed ID: 25288026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review.
    Häuser W; Bartram C; Bartram-Wunn E; Tölle T
    Clin J Pain; 2012 Jun; 28(5):437-51. PubMed ID: 22336767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials.
    Mahr A; Golmard C; Pham E; Iordache L; Deville L; Faure P
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):731-741. PubMed ID: 28176407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocebo effects and psychotropic drug action.
    Amanzio M
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):159-61. PubMed ID: 25494811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.
    Gupta A; Thompson D; Whitehouse A; Collier T; Dahlof B; Poulter N; Collins R; Sever P;
    Lancet; 2017 Jun; 389(10088):2473-2481. PubMed ID: 28476288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
    Josiassen RC; Kane JM; Liang GS; Burke J; O'Brien CF
    Psychopharmacol Bull; 2017 Aug; 47(3):61-68. PubMed ID: 28839341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of nocebo effects of antiepileptic drugs across different conditions.
    Zaccara G; Giovannelli F; Giorgi FS; Franco V; Gasparini S
    J Neurol; 2016 Jul; 263(7):1274-9. PubMed ID: 26810717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
    Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
    J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA; Levine SZ; Tanaka S; Goldberg Y; Samara M; Davis JM; Cipriani A; Leucht S
    JAMA Psychiatry; 2015 Jan; 72(1):14-21. PubMed ID: 25372935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
    Kravvariti E; Kasdagli MI; Diomatari KM; Mouratidou P; Daskalakis K; Mitsikostas DD; Sfikakis PP; Yavropoulou MP
    Osteoporos Int; 2023 Mar; 34(3):585-598. PubMed ID: 36596944
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.